• Using the search terms atorvastatin, simvastatin,pravastatin, rosuvastatin, fluvastatin, lovastatin, prospective trial, and randomized trial, the MEDLINE/EMBASE and the Cochrane Collaboration databases were reviewed for prospective randomized primary and secondary prevention trials of statin monotherapy. (unboundmedicine.com)
  • Comparative assessment of environmental risk when using simvastatin, atorvastatin, rosuvastatin, pravastatin and ezetimibe from a Swedish perspective. (janusinfo.se)
  • The risk seems entirely insignificant for the highly water-soluble substance rosuvastatin. (janusinfo.se)
  • The aim of this study was to investigate, and compare with pravastatin and simvastatin, the tissue-specific distribution of rosuvastatin. (aspetjournals.org)
  • Bolus intravenous doses (5 mg/kg) of radiolabeled rosuvastatin, pravastatin, and simvastatin were administered to rats, and initial uptake clearance (CL uptake ) in various tissues was calculated. (aspetjournals.org)
  • 0.001) larger than that of pravastatin (0.703 ml/min/g tissue), and rosuvastatin was taken up by the hepatic cells more selectively and efficiently than pravastatin. (aspetjournals.org)
  • After administration of rosuvastatin and pravastatin, silver grains were distributed selectively in the intracellular space of the liver, but more rosuvastatin (3.3 ± 1.0 × 10 5 particles/mm 2 ) than pravastatin (2.0 ± 0.3 × 10 5 particles/mm 2 ) tended to distribute to the liver. (aspetjournals.org)
  • The results of this study indicated that rosuvastatin was taken up by hepatic cells more selectively and more efficiently than pravastatin and simvastatin. (aspetjournals.org)
  • 14 C]Rosuvastatin (1.15 MBq/mg), [ 14 C]pravastatin (1.17 MBq/mg), and [ 14 C]simvastatin (1.85 MBq/mg) were synthesized at Shionogi and Co., Ltd. (Osaka, Japan). (aspetjournals.org)
  • 14 C]Rosuvastatin and [ 14 C]pravastatin were dissolved in physiological saline. (aspetjournals.org)
  • 8.4 nmol/L and high-sensitivity CRP (hsCRP) is 0.8 mg/L. She is a marathon runner and was previously unable to tolerate atorvastatin, rosuvastatin, or a higher dose of pravastatin due to muscle pain after running. (acc.org)
  • Other variants of the drug include fluvastatin (Lescol), pravastatin (Lipostat), rosuvastatin (Crestor) and simvastatin (Zocor). (express.co.uk)
  • Because the benefits of statins may include prevention of serious or potentially fatal events in a small group of very high-risk pregnant patients, contraindicating these drugs in all pregnant women is not appropriate. (medlineplus.gov)
  • Patients who are at high risk of heart attack or stroke who require statins after giving birth should not breastfeed and should use alternatives such as infant formula. (medlineplus.gov)
  • Pravastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). (medlineplus.gov)
  • Our study demonstrated that persistent use of statins is associated with a lower overall cancer risk and particularly the risk of incident hematopoietic malignancies. (cdc.gov)
  • Large randomized controlled trials (RCTs) that examined the safety and effectiveness of statins in preventing cardiovascular diseases indicated that statins were not associated with increased cancer risk (5). (cdc.gov)
  • Statins have been associated with a significantly lower risk of breast (8), colorectal (9), and lymph cancers (10-12) in several observational studies (10,13). (cdc.gov)
  • The objective of this study was to investigate the association between persistent use of statins and the risk of overall and site-specific cancer in adults, to assess dose-response relationship, and to examine the effects of varying types of statins. (cdc.gov)
  • More fat-soluble statins (simvastatin, atorvastatin) may be quite potent and (together with ezetimibe) represent a slightly higher risk than the others, but the levels in the environment are probably well below the concentrations that give rise to effects. (janusinfo.se)
  • We are led to believe that the benefits associated with statins far outweigh any risks. (greenmedinfo.com)
  • Thus, even before we start to assess the risks associated with statins, we can see that there is no meaningful net benefit where primary prevention is concerned. (greenmedinfo.com)
  • Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. (sciencedaily.com)
  • John Albers and colleagues compared the effects of two commercially used statins, simvastatin and pravastatin, on two different types of brain cells, neurons and astrocytes (support cells that help repair damage). (sciencedaily.com)
  • Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients with high risk for cardiovascular disease: the CLEAR wisdom randomized clinical trial. (acc.org)
  • If you are in the highest risk group possible (men of a certain age who have already had a heart attack), for every 100 of these men given statins for five years, 1.8 men will live, on average, an extra 6 months and 98.2 will gain no benefit. (zoeharcombe.com)
  • 15-17 Employers and commercial insurers bear significant medical cost and productivity burdens associated with undertreatment of hypercholesterolemia and poor compliance with statins, particularly for the high-risk population. (ahdbonline.com)
  • There appears to be no clear reduction in coronary heart disease mortality in western European countries from statins for primary [low-risk patients] and secondary prevention [high-risk patients]. (express.co.uk)
  • 1-3 Primary prevention with statins has also been shown in large populations of asymptomatic individuals at increased risk for coronary disease 4 , 5 (fig 1). (bmj.com)
  • Discussing options for people with newly defined very high risk of atherosclerotic cardiovascular disease (ASCVD) who still have LDL cholesterol levels higher than 70 mg/dL after maximizing statins. (healthywomen.org)
  • Strategies to lower cardiovascular risk with statins should include monitoring CRP as well as cholesterol. (natap.org)
  • Statins are successful, widely used drugs that decrease the risk of coronary heart disease and strokes by lowering cholesterol levels. (manchester.ac.uk)
  • Although pravastatin generally has fewer drug interactions compared to other statins, it's still crucial that your physician be aware of any additional medications you are taking because some of them might significantly raise your chance of developing serious muscle issues. (marleydrug.com)
  • Like other members of its class (the "statins"), simvastatin lowers total serum cholesterol and particularly low density lipoprotein (LDL) cholesterol concentrations, thereby reducing the risk of atherosclerosis and its complications - myocardial infarction and stroke. (nih.gov)
  • I would suggest alternative statins which may be less likely to cause muscle cramps as the next most reasonable step (pitavastatin, pravastatin) rather than going directly to a non-statin or a non-medication solution. (texasheart.org)
  • But last year the Food and Drug Administration declared that statins taken with protease inhibitors-found in many HIV meds-increase the risk of muscle injury and could lead to kidney failure in some patients. (hivplusmag.com)
  • Atorvastatin was associated with the greatest risk of AEs and fluvastatin with the least risk. (unboundmedicine.com)
  • atorvastatin) even though both of simvastatin and pravastatin could activate mevalonate pathways, suggesting the statin-mediated antiproliferative effects depended on non-mevalonate pathway. (nih.gov)
  • Current guidance recommends that GPs should offer 20mg of atorvastatin to people with a risk of 10 per cent or greater of developing cardiovascular disease within the next 10 years. (express.co.uk)
  • Methods: We evaluated relationships between the LDL cholesterol and CRP levels achieved after treatment with 80 mg of atorvastatin or 40 mg of pravastatin per day and the risk of recurrent myocardial infarction or death from coronary causes among 3745 patients with acute coronary syndromes. (natap.org)
  • Simvastatin and Pravastatin: Concomitant use results in increased concentrations and increased risk of simvastatin or pravastatin-related myopathy. (globenewswire.com)
  • Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial. (medscape.org)
  • Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. (medscape.org)
  • Evaluating the use of pitavastatin to reduce the risk of cardiovascular disease in HIV-infected adults (REPRIEVE). (medscape.org)
  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. (nih.gov)
  • Lowering the blood cholesterol level may reduce the risk of coronary heart disease. (nih.gov)
  • This double-blind study was designed to determine whether the administration of pravastatin to men with hypercholesterolemia and no history of myocardial infarction reduced the combined incidence of nonfatal myocardial infarction and death from coronary heart disease. (nih.gov)
  • To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). (nih.gov)
  • To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. (nih.gov)
  • Primordial prevention usually refers to healthy lifestyle choices to prevent the development of coronary risk factors. (medscape.com)
  • To assess associations between baseline values of four different circulating markers of inflammation and future risk of coronary heart disease, potential triggers of systemic inflammation (such as persistent infection), and other markers of inflammation. (bmj.com)
  • Compared with men in the bottom third of baseline measurements of C reactive protein, men in the top third had an odds ratio for coronary heart disease of 2.13 (95% confidence interval 1.38 to 3.28) after age, town, smoking, vascular risk factors, and indicators of socioeconomic status were adjusted for. (bmj.com)
  • Several reports have suggested that plasma C reactive protein and other possible markers of low grade inflammation can predict increased risks of coronary heart disease, but it is not known whether the associations are causal. (bmj.com)
  • These markers of inflammation might, however, be indicators of chronic infective processes possibly correlated with risk of coronary heart disease, such as infection by Chlamydia pneumoniae or chronic gastric infection with Helicobacter pylori . (bmj.com)
  • However, colchicine has been shown to reduce major adverse cardiovascular events in patients with chronic coronary disease, particularly in those with residual inflammatory risk. (acc.org)
  • The target population consists of working-age people who are considered high-risk for cardiovascular disease events because of a history of coronary heart disease. (ahdbonline.com)
  • Using Framingham risk scoring system, the probability of myocardial infarction or stroke events was calculated for a representative sample population, ages 35 to 69 years, of people at high risk for cardiovascular disease, with a history of coronary heart disease. (ahdbonline.com)
  • The high-risk cohort (those with coronary heart disease) comprises 4% of the 35- to 69-year-old commercially insured population but generates 22% of the risk for coronary heart disease and stroke. (ahdbonline.com)
  • 1 Hypercholesterolemia, particularly elevated lowdensity lipoprotein cholesterol (LDL-C), is strongly associated with an increased risk of CVD, including coronary heart disease (CHD) events (ie, myocardial infarction [MI], angina, coronary revascularization) and stroke. (ahdbonline.com)
  • 5) Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO MONICA project. (guiasalud.es)
  • These benefits have been seen in patients with coronary heart disease and high or normal blood cholesterol concentrations, as well as in asymptomatic patients at increased risk for coronary heart disease. (bmj.com)
  • Background It has been reported previously that the measurement of plasma total adiponectin level is clinically useful to estimate the risk of coronary artery disease (CAD). (go.jp)
  • Learning about your risk factors and how to manage them is the best way to prevent future blockages in your coronary arteries. (ottawaheart.ca)
  • Specifically, on an a priori basis, we hypothesized that patients with acute coronary syndromes who had lower CRP levels as a result of statin therapy would have a lower risk of recurrent myocardial infarction or death from coronary causes than those who had higher CRP levels, even after we controlled for the achieved levels of LDL cholesterol. (natap.org)
  • Pravastatin is used to lower your blood levels of low-density lipoprotein (LDL) and total cholesterol to prevent the development of plaque in your arteries and lower the risk of coronary heart disease. (marleydrug.com)
  • In both individuals with and without coronary heart disease or other risk factors, pravastatin is used to reduce the risk of stroke, heart attack, and other heart problems. (marleydrug.com)
  • Current indications for simvastatin are hypercholesterolemia and reduction in risk for death from coronary, cerebrovascular and peripheral artery disease in patients with these diseases. (nih.gov)
  • A recent study has found that a ceramide- and phospholipid-based risk score, not LDL cholesterol (LDL-C), can efficiently predict residual cardiovascular disease (CVD) event risk in patients with coronary heart disease (CHD). (hcplive.com)
  • While investigators concluded that ceramide-phospholipid risk score showed comparable and synergistic predictive performance when compared with previously published CVD risk models, they also found that there was variability in the risk of CVD events in patients with coronary artery disease. (hcplive.com)
  • The 3 studies that investigators pooled data from were the Western Norway Coronary Angiography Cohort (WECAC), the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) trial, and Langzeiterfolge der KARdiOLogischen Anschlussheilbehandlung (KAROLA). (hcplive.com)
  • Treatment of elevated LDLc levels is based upon the risk for a coronary heart disease (CHD) event (see Table 1). (medscape.com)
  • Adults with HIV or AIDS may be at an increased risk for development of coronary heart disease due to many factors, including the effects of increasingly older age of patients with HIV and long-term exposure and side effects to antiretroviral therapies that can cause high cholesterol and other metabolic abnormalities," Craig Sponseller, vice president of medical affairs for Livalo's maker, Kowa Pharmaceuticals America, told HIV Plus . (hivplusmag.com)
  • Her current medications include aspirin 81mg, pravastatin 20mg, ezetimibe 10mg, and amlodipine 2.5mg daily. (acc.org)
  • Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of myocardial infarction. (nih.gov)
  • Background It is unclear whether early initiation of low-dose pravastatin therapy can reduce the occurrence of major adverse cardiac events after acute myocardial infarction (AMI). (go.jp)
  • Percent risk for developing CHD or having a major CHD event (ie, fatal or nonfatal myocardial infarction) is determined by calculating the Framingham risk score, which is available through the US National Heart, Lung, and Blood Institute (see Risk Assessment Tool for Estimating 10-Year Risk of Developing Hard CHD). (medscape.com)
  • The recommended starting dose of pravastatin is 20 mg daily, taken with or without food in a single dose at bedtime. (medbroadcast.com)
  • We randomly assigned 6595 men, 45 to 64 years of age, with a mean (+/- SD) plasma cholesterol level of 272 +/- 23 mg per deciliter (7.0 +/- 0.6 mmol per liter) to receive pravastatin (40 mg each evening) or placebo. (nih.gov)
  • The patients were randomly assigned to either receive pravastatin (10 mg/daily, n=176) or not (n=177). (go.jp)
  • While the recent findings on Livalo don't mention its impact on muscle health, they do indicate the drug is a better bet for heart health in HIV-positive people than another statin, called pravastatin. (hivplusmag.com)
  • Livalo provided significantly greater low-density lipoprotein reduction compared with pravastatin in HIV-infected adults with high cholesterol," according to data presented by Kowa at the Endocrine Society's Annual Meeting last June. (hivplusmag.com)
  • The doctor must review the liver every so often because of the risk with this medication. (aapc.com)
  • Cessation of breastfeeding may have consequences for the mother and baby and a recommendation to stop should not be undertaken without examining the literature for benefit and risk to the baby of the medication. (breastfeedingnetwork.org.uk)
  • Because the full impact of this medication is seen within 4 weeks, frequent lipid assessments should be done at this time, and the dosage should be changed by your response to pravastatin. (marleydrug.com)
  • If you do get pregnant while taking this medication, stop taking pravastatin and notify your doctor immediately. (marleydrug.com)
  • Your doctor will advise you on whether you should discontinue this medication during pregnancy and if you should temporarily stop using pravastatin while nursing or breastfeeding. (marleydrug.com)
  • These highlights do not include all the information needed to use PRAVASTATIN SODIUM TABLETS safely and effectively. (nih.gov)
  • See full prescribing information for PRAVASTATIN SODIUM TABLETS. (nih.gov)
  • For patients that require a high-intensity statin or are unable to achieve their LDL-C goal receiving pravastatin sodium tablets 80 mg daily, prescribe alternative LDL-C-lowering treatment ( 2.1 ). (nih.gov)
  • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating pravastatin sodium, and adjust the dosage if necessary ( 2.1 ). (nih.gov)
  • Adults: recommended starting dosage is pravastatin sodium tablets 40 mg to 80 mg once daily. (nih.gov)
  • Severe renal impairment: recommended starting dosage is pravastatin sodium 10 mg once daily. (nih.gov)
  • Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher pravastatin sodium dosage. (nih.gov)
  • Discontinue pravastatin sodium if markedly elevated CK levels occur or myopathy is diagnosed or suspected. (nih.gov)
  • Temporarily discontinue pravastatin sodium in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis. (nih.gov)
  • Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing pravastatin sodium dosage. (nih.gov)
  • Discontinue pravastatin sodium if IMNM is suspected ( 5.2 ). (nih.gov)
  • Use another pravastatin sodium product to initiate dosing. (nih.gov)
  • Comment: OATP1B1 inhibitors may increase risk of myopathy. (medscape.com)
  • Feb. 28, 2023 The study found that in patients at high risk of developing cardiovascular disease, over 20 percent refused to take statin medications. (sciencedaily.com)
  • Health care professionals should discontinue statin therapy in most pregnant patients, or they can consider the ongoing therapeutic needs of the individual patient, particularly those at very high risk for cardiovascular events during pregnancy. (medlineplus.gov)
  • Describe the relevance of the finding that simvastatin, but not pravastatin, seems to interfere with sleep quality and increase patient-reported sleep problems to clinicians in the care of their patients receiving statin therapy. (medscape.org)
  • To model the financial and health outcomes impact of intensive statin therapy compared with usual care in a high-risk working-age population (actively employed, commercially insured health plan members and their adult dependents). (ahdbonline.com)
  • Our analysis models the cost impact of aggressive statin therapy for a commercially insured cohort of members at high risk for secondary events from CVD as a result of a history of CHD. (ahdbonline.com)
  • Using this newly developed model, we compare the CVD event and cost burden under conventional current therapy to represent the results of intensive statin therapy, which is the current standard of care for high-risk patients. (ahdbonline.com)
  • Statin therapy lowers the risk of cardiovascular events by reducing plasma cholesterol levels, and practice guidelines for patients with known cardiovascular disease emphasize the importance of reaching target goals for low-density lipoprotein (LDL) cholesterol. (natap.org)
  • Thus, these data suggest that strategies that aggressively lower cardiovascular risk by means of statin therapy may need to include monitoring of the levels of inflammation as well as cholesterol. (natap.org)
  • Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. (medscape.org)
  • Pravastatin lowered plasma cholesterol levels by 20 percent and low-density-lipoprotein cholesterol levels by 26 percent, whereas there was no change with placebo. (nih.gov)
  • Pravastatin is also used to reduce the amount of fatty substances such as low-density lipoprotein (LDL) cholesterol ('bad cholesterol') and triglycerides in the blood and to increase the amount of high-density lipoprotein (HDL) cholesterol ('good cholesterol') in the blood. (medlineplus.gov)
  • Aggressive low-density lipoprotein cholesterol-lowering therapy for working-age people at high risk for cardiovascular events and with a history of heart disease appears to have a significant potential to reduce the rate of clinical events and is cost-neutral for payers. (ahdbonline.com)
  • Additionally, pravastatin is used in adults and adolescents as young as 8 years old in conjunction with a proper diet to reduce triglyceride levels and "bad" cholesterol (LDL, is a type of fat in the blood), while increasing high-density lipoprotein (HDL) levels. (marleydrug.com)
  • FDA expects removing the contraindication will enable health care professionals and patients to make individual decisions about benefit and risk, especially for those at very high risk of heart attack or stroke. (medlineplus.gov)
  • ABSTRACT To determine frequency of cardiovascular risk factors in Saudi and non-Saudi diabetics, we studied patients attending King Abdulaziz University Hospital for follow-up in the period January 1997 to December 2001. (who.int)
  • The study tion was used to study the correlation of group comprised 1155 diabetic patients, all different cardiovascular risk factors to age. (who.int)
  • Conclusion For patients with AMI, early and low-dose pravastatin therapy (10 mg/daily) reduces recurrent major adverse cardiac events, mostly the requirement for revascularization. (go.jp)
  • The 2018 ACC/AHA Guidelines on the Management of Blood Cholesterol allow for more personalized care for patients, including more detailed risk assessments and new cholesterol-lowering drug options for people at the highest risk for heart disease. (healthywomen.org)
  • Overall, there's a new emphasis on making sure the highest risk patients receive the treatment they need. (healthywomen.org)
  • It is common to assume that all CHD patients have an equivalent cardiovascular risk, but according to this study this seems not to be the case. (hcplive.com)
  • Within their conclusion, authors wrote that CERT2 scores offer an easy to use tool for estimation residual risk in patients with CHD. (hcplive.com)
  • Patients at high or very high risk have an optional LDLc goal of less than 70 mg/dL. (medscape.com)
  • Treatment is started when patients and their family are focused on the patient's cardiovascular risk. (slideshare.net)
  • [ 4 ] raise two important clinical issues in regards to the management of CV risk in patients with hypertriglyceridaemia. (medscape.com)
  • 3 mmol/L) that is not statin eligible as defined according to the 2016 ESC/EAS guidelines, but has a ASCVD risk equivalent to statin-eligible patients. (medscape.com)
  • Pravastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. (medlineplus.gov)
  • Pravastatin can be used to reduce the risk of death, heart attacks, stroke, angioplasty, and hospitalization for people with heart disease and normal to moderately high cholesterol. (medbroadcast.com)
  • This is linked to higher risk for heart attack and stroke. (uhhospitals.org)
  • High blood cholesterol is a major risk factor for heart disease and stroke. (uhhospitals.org)
  • There were no significant differences in the risk of death, nonfatal MI, UA, and stroke between the 2 groups, although the pravastatin group had a lower risk of need for revascularization. (go.jp)
  • The ACC/AHA guidelines also endorsed a specific risk assessment tool, which assesses your 10-year risk of heart disease or stroke. (healthywomen.org)
  • Having high cholesterol puts you at risk for a heart attack or stroke. (healthline.com)
  • Pravastatin comes as a tablet to take by mouth. (medlineplus.gov)
  • Pravastatin can be taken with or without food and is available in tablet form. (marleydrug.com)
  • The article, entitled "Bempedoic acid in the management of lipid disorders and cardiovascular risk. (esperion.com)
  • Also, in addition to traditional risk factors for high cholesterol such as smoking, high blood pressure and high blood sugar, the 2018 guidelines add factors such as certain health conditions including metabolic syndrome, kidney disease, premature menopause, chronic inflammatory diseases and high lipid biomarkers. (healthywomen.org)
  • The US Food and Drug Administration (FDA) has updated its quarterly watch list with four dozen drugs and drug classes because it has received new safety information or identified possible signs of serious risk - including serious risks from conditions such as anaphylaxis, herpes zoster, and fetal death. (medscape.com)
  • Six drugs/drug classes were added to the list for potential risk of fetal death. (medscape.com)
  • An X designation is given when, "Studies in animals or humans have demonstrated fetal abnormalities…and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits. (preeclampsia.org)
  • The objective of this study was to investigate the association between persistent statin use and the risk of primary cancer in adults. (cdc.gov)
  • 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (medscape.org)
  • Tablets is used due to the risk of adverse effects or loss of efficacy due to drug-drug interactions (see also sections 4.4. (who.int)
  • Nguyen (2019) reported that ever breastfeeding was associated with lower risk of CVD hospitalisation and mortality compared with never breastfeeding, and breastfeeding ≤12 months/child was significantly associated with lower risk of CVD hospitalisation. (breastfeedingnetwork.org.uk)
  • NICHD also wants to better support pregnant women who have high-risk pregnancy conditions like gestational diabetes and obesity. (medlineplus.gov)
  • NICHD-supported research is also testing whether drugs such as pravastatin-normally used to treat high cholesterol-can help prevent preeclampsia. (medlineplus.gov)
  • NICHD recently launched the Pregnancy for Every Body Initiative, since plus-size women are at a higher risk for pregnancy complications. (medlineplus.gov)
  • The patient has clinical ASCVD but is not at very high risk based on the ACC Expert Consensus Decision Pathway. (acc.org)
  • While statin intake has been proven to reduce the risk of colorectal cancer (CRC), the mechanism of antitumor effects and clinical significance in survival benefits remain unclear. (nih.gov)
  • Risk estimation and the prevention of cardiovascular disease: a national clinical guideline. (guiasalud.es)
  • The treatment of Familial Hypercholesteraemia is recommended to reduce the risk of future cardiovascular events. (breastfeedingnetwork.org.uk)
  • Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. (medscape.org)
  • Does Pravastatin During Pregnancy Have Long-term Effects On Children? (preeclampsia.org)
  • If given in early pregnancy pravastatin, (a drug used to lower cholesterol) may decrease the risk of developing preeclampsia. (preeclampsia.org)
  • The X classification for pravastatin was based primarily on the fact that there was no known indication for use in pregnancy, and therefore any possible risk outweighed benefit. (preeclampsia.org)
  • Based on limited data, pravastatin use during pregnancy does not appear to have any long-term adverse effects on children. (preeclampsia.org)
  • Each quarter, our team of science writers reviews the most current research studies related to hypertensive disorders of pregnancy and summarizes those studies of greatest interest and potential impact to our community, including research studies related to risk assessment, diagnosis, prevention, and treatment. (preeclampsia.org)
  • Discontinue bempedoic acid when pregnancy is recognized, unless the benefits of therapy outweigh the potential risks to the fetus. (globenewswire.com)
  • But it also can be difficult and confusing, especially for women with a high-risk pregnancy. (medlineplus.gov)
  • Factors like a woman's age, her lifestyle, and preexisting conditions can all contribute to a high-risk pregnancy. (medlineplus.gov)
  • During a high-risk pregnancy, a woman and her unborn child are at increased risk of problems during pregnancy or labor, like early birth or miscarriage. (medlineplus.gov)
  • It is also used to reduce the risk of heart attacks, angioplasty, and death for people with high cholesterol who do not already have heart disease. (medbroadcast.com)
  • Be sure to take your pravastatin dosage either 1 hour before or 4 hours after taking cholestyramine or colestipol if you take either of those medications. (marleydrug.com)
  • University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. (manchester.ac.uk)
  • The paper ' Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum' , was published in Proceedings of the National Academy of Sciences. (manchester.ac.uk)
  • Increased levels of antibody induced by vaccination decrease the risk for illness caused by strains that are antigenically similar to those strains of the same type or subtype included in the vaccine ( 3 , 112-114 ). (cdc.gov)
  • It will also provide the necessary information for adjusting the dosage to the lowest effective dose, thus decreasing the risk of adverse effects. (groupeproxim.ca)
  • Pravastatin is a low- to moderate-intensity statin depending on the dosage. (marleydrug.com)
  • Lowering cholesterol levels in the blood has been shown to reduce the risks associated with heart disease, such as heart attack. (medbroadcast.com)
  • If the sharp short term fluctuations are ignored, then long term circulating concentrations of these factors show a similar year-to-year consistency within individuals to levels of some more extensively studied risk factors such as blood cholesterol concentration and blood pressure. (bmj.com)
  • While increased levels of these two proteins may account for potential risks of disease, Albers and colleagues also note that large decreases in cholesterol proteins like ABCA1 should be considered. (sciencedaily.com)
  • 5-14 More recent studies have shown that intensive reduction of LDL-C levels in high-risk individuals with a history of CHD is associated with an even greater reduction in CVD events than conventional LDL-C lowering. (ahdbonline.com)
  • Start keeping track of your cholesterol levels and other risk factors regularly at age 20. (uhhospitals.org)
  • Levels above 60 mg/dL are considered especially beneficial and can offset risk factors for heart disease, according to AHA. (healthywomen.org)
  • Below these levels is considered a major risk factor for heart disease. (healthywomen.org)
  • The 2001 National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATPIII) defined target LDLc levels and levels based on risk for CHD. (medscape.com)
  • Many countries where CHD is on the rise have instituted counselling and educational methods to encourage people to reduce their risks for developing heart disease. (medscape.com)
  • Though you didn't mention the LDL/HDL breakdown - assuming your cholesterol is that high for genetic reasons, dietary changes alone, though important, are not likely to reduce your risk as much as one would like. (texasheart.org)
  • Additionally, the C-statistics in WECAC for the risk score combined with sex and age was 0.76 for CVD death. (hcplive.com)
  • Dyslipidemia, along with glucose abnormalities, places those who are HIV-positive at elevated risk for cardiovascular disease, such as hardening of the arteries and heart attacks. (hivplusmag.com)
  • Low-density lipoproteins contribute to fat buildup in the arteries and are a risk factor for heart disease. (hivplusmag.com)
  • Lowering your blood level of cholesterol and fats with pravastatin has been shown to prevent heart disease, angina (chest pain), strokes, and heart attacks. (medlineplus.gov)
  • However, if left untreated, high cholesterol can increase your risk of cardiovascular problems like heart disease and strokes. (euroclinix.net)
  • Even in the highest male risk groups for heart disease, statin treatment resulted in 0.5 % fewer deaths per year, and this small benefit was found in the most positive of all trials. (thincs.org)
  • 30 kg/m2], smoking history programme to state that, in terms of car- (either active or less than 5 years since ces- diovascular risk, DM was equivalent to sation of smoking) were recorded from the having ischaemic heart disease [ 3 ]. (who.int)
  • Screenings help find people at risk for heart disease. (uhhospitals.org)
  • Check it earlier if you have an increased risk for either high cholesterol or heart disease. (uhhospitals.org)
  • Higher numbers indicate a higher risk of heart disease. (healthywomen.org)
  • Coadministration of tucatinib (a CYP2C8 substrate) with a strong or moderate CYP2C8 inhibitors increases tucatinib plasma concentrations and risk of toxicities. (medscape.com)
  • Pethidine, piroxicam, Increased plasma concentrations of norpethidine, propoxyphene piroxicam and propoxyphene, thereby, increasing the risk of serious respiratory depression or haematologic abnormalities, or other serious adverse effects from these agents. (who.int)
  • Assessment report for Pravafenix (fenofibrate, pravastatin) EMA/333119/2011. (janusinfo.se)
  • The environmental risk assessment (ERA) is based on data from bibliographic references on fenofibrate and pravastatin. (janusinfo.se)
  • Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease CG67. (guiasalud.es)
  • Hi Judy, Your profile sounds fairly high-risk with high cholesterol and family history. (texasheart.org)
  • The primary target of therapy is LDL cholesterol, unless serum triglycerides are 500 mg/dL in which case triglyceride-lowering therapy should be started immediately because of the high risk of pancreatitis. (who.int)
  • You can lower your risk by getting more exercise, losing weight if you are overweight, quitting smoking, and eating a healthy diet. (uhhospitals.org)